These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7628120)

  • 1. Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease.
    Wick U; Witt E; Engel W
    Clin Genet; 1995 Apr; 47(4):184-90. PubMed ID: 7628120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage disequilibrium of the Apo AI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans.
    Song J; Park JW; Park H; Kim JQ
    Mol Cells; 1998 Feb; 8(1):12-8. PubMed ID: 9571626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease.
    Paulweber B; Friedl W; Krempler F; Humphries SE; Sandhofer F
    Atherosclerosis; 1988 Oct; 73(2-3):125-33. PubMed ID: 2903749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.
    Xu CF; Nanjee MN; Savill J; Talmud PJ; Angelico F; Del Ben M; Antonini R; Mazzarella B; Miller N; Humphries SE
    Am J Hum Genet; 1990 Sep; 47(3):429-39. PubMed ID: 1975478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary heart disease, echo-Doppler evidence of peripheral arterial disease and polymorphism of apolipoprotein B gene and Apo AI/CIII cluster.
    De Lorenzo F; Rubba P; Monticelli A; Cocozza S
    Angiology; 1993 Oct; 44(10):785-90. PubMed ID: 8105730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Within-individual variation in serum cholesterol levels: association with DNA polymorphisms at the apolipoprotein B and AI-CIII-AIV loci in patients with peripheral arterial disease.
    Monsalve MV; Robinson D; Woolcock NE; Powell JT; Greenhalgh RM; Humphries SE
    Clin Genet; 1991 Apr; 39(4):260-73. PubMed ID: 1676938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study.
    Porkka KV; Taimela S; Kontula K; Lehtimäki T; Aalto-Setälä K; Akerblom HK; Viikari JS
    Clin Genet; 1994 Mar; 45(3):113-21. PubMed ID: 7913004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia.
    Buzza M; Fripp Y; Mitchell RJ
    Ann Hum Biol; 2001; 28(5):481-90. PubMed ID: 11572515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease.
    Price WH; Morris SW; Kitchin AH; Wenham PR; Burgon PR; Donald PM
    Lancet; 1989 Jun; 1(8652):1407-11. PubMed ID: 2567428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones.
    Kessling A; Ouellette S; Bouffard O; Chamberland A; Bétard C; Selinger E; Xhignesse M; Lussier-Cacan S; Davignon J
    Am J Hum Genet; 1992 Jan; 50(1):92-106. PubMed ID: 1346081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy.
    De Lorenzo F; Monticelli A; Cocozza S; De Simone B; Rubba P
    Clin Investig; 1994 Jun; 72(6):435-41. PubMed ID: 7950154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA polymorphisms of apolipoprotein B and AI-CII-AIV genes in a Brazilian population: a preliminary report.
    Bydlowski SP; Novak EM; Issa JS; Forti N; Giannini SD; Diament J
    Braz J Med Biol Res; 1996 Oct; 29(10):1269-74. PubMed ID: 9181096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism.
    Espino-Montoro A; Barrios-Artillo M; López-Chozas JM; Cayuela A; Stiefel P; Villar J
    Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):194-201. PubMed ID: 14650351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects.
    Zhang Q; Liu Y; Liu BW; Fan P; Cavanna J; Galton DJ
    Mol Genet Metab; 1998 Jul; 64(3):177-83. PubMed ID: 9719626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.
    Wile DB; Barbir M; Gallagher J; Myant NB; Ritchie CD; Thompson GR; Humphries SE
    Atherosclerosis; 1989 Jul; 78(1):9-18. PubMed ID: 2569310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11.
    Marasco O; Melina F; Mele E; Quaresima B; Zingone A; Focarelli E; Picciotti E; Martelli ML; Fotino L; Vigna MF
    Hum Genet; 1993 Mar; 91(2):169-74. PubMed ID: 8096493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls.
    Xu CF; Angelico F; Del Ben M; Humphries S
    Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.